News

Beit Jala Pharmaceutical Company Invitation for Regular General Assembly Meeting for 2025 Based on Article (197) of the Companies Law No. (42) of 2021 and Article (58) of the company’s bylaws, the Board of Directors is pleased to invite the esteemed shareholders of Beit Jala Pharmaceutical Company, a public shareholding company, to attend the regular

Beit Pharmaceutical Company Invitation to Attend the Extraordinary General Assembly Meeting Based on Article (180) of the Companies Law No. (42) of 2021, the Board of Directors is pleased to invite the esteemed shareholders of Beit Jala Pharmaceutical Company to attend the extraordinary general assembly meeting, which will be held on Sunday, 16/11/2025, at 11:00

Request for Proposal TechnicalTechnicalTechnicalTechnicalTechnicalTechnicalTechnicalTechnicalTechnical services/ Promotional Activities (Design and Implementation Design and Implementation Design and Implementation Design and Implementation Design and Implementation Design and Implementation Design and Implementation Design and Implementation Design and Implementation Design and Implementation Design and Implementation Design and Implementation Design and Implementation Design and Implementation Design and Implementation Design and Implementation

The Beit Jala Pharmaceutical Industry Company signed a joint cooperation agreement with Al-Quds University in the presence of Mr. Hamad Al-Masry, Vice Chairman of the Board of Directors, Dr. Walid Al-Kamel, General Manager, and Dr. Youssef Najajreh. The university was represented by its president, Dr. Imad Abu Kishk. This is to embody the partnership and